Effect of obesity, serum lipoproteins, and apolipoprotein E genotypes on mortality in hospitalized elderly patients.

BACKGROUND The aim of this study was to investigate the relationship among apolipoprotein E (APOE) polymorphism, body mass index (BMI), and dyslipidemia and how these factors modify overall mortality in a cohort of hospitalized elderly patients. METHODS Plasma concentrations of total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), BMI, and APOE genotype were evaluated in 1,012 hospitalized elderly patients, who were stratified into three groups according to their baseline BMI and APOE allele status. Multivariate logistic regression analysis was used to assess whether APOE genotype, BMI, and dyslipidemia are associated with mortality, adjusting for potential confounders. Interaction analysis was also performed. RESULTS Obese patients have significantly higher levels of TC and LDL-C compared to normal-weight and overweight subjects, for both sexes. APOE ε4 carriers have significantly higher levels of TC and LDL-C compared with ε2 and ε3 carrier both in males and females. Interaction analysis showed that women with TC < 180  mg/dL, LDL-C < 100  mg/dL, normal weight, and ε3 carrier (odds ratio [OR] = 3.42, 95% confidence interval [CI] 1.36-8.60) and men with LDL-C < 100  mg/dL, HDL-C < 40  mg/dL, and ε3 carrier (OR = 1.97, 95% CI 1.04-3.74) were at highest risk of mortality. CONCLUSIONS In elderly hospitalized patients, obesity and APOE genotype influence the lipid profile and mortality risk. A significant interaction among BMI, dyslipidemia, and APOE genotype was observed that could identify elderly patients with different risks of mortality.

[1]  R. Luben,et al.  APOE genotype, lipids, and coronary heart disease risk: a prospective population study. , 2009, Archives of internal medicine.

[2]  F. Panza,et al.  Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease , 2009, Ageing Research Reviews.

[3]  D. C. Pant,et al.  Association of cholesteryl ester transfer protein (TaqIB) and apolipoprotein E (HhaI) gene variants with obesity , 2008, Molecular and Cellular Biochemistry.

[4]  Bernard Keavney,et al.  Association of apolipoprotein E genotypes with lipid levels and coronary risk. , 2007, JAMA.

[5]  I. Janssen Morbidity and Mortality Risk Associated With an Overweight BMI in Older Men and Women , 2007, Obesity.

[6]  F. Panza,et al.  Apolipoprotein E Genotypes in Hospitalized Elderly Patients with Vascular Dementia , 2007, Dementia and Geriatric Cognitive Disorders.

[7]  I. Janssen,et al.  Elevated body mass index and mortality risk in the elderly , 2007, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[8]  D. Seripa,et al.  Simple and Effective Determination of Apolipoprotein E Genotypes by Positive/Negative Polymerase Chain Reaction Products , 2006, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[9]  T. Harris,et al.  Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. , 2006, The New England journal of medicine.

[10]  Elizabeth Breeze,et al.  Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death. , 2006, The American journal of clinical nutrition.

[11]  C. Sudlow,et al.  Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. , 2006, Stroke.

[12]  J. Staessen,et al.  Low‐Density Lipoprotein Cholesterol and Mortality in Older People , 2005, Journal of the American Geriatrics Society.

[13]  P. Zandi,et al.  Apolipoprotein E Genotype and Mortality: Findings from the Cache County Study , 2005, Journal of the American Geriatrics Society.

[14]  R. Mayeux,et al.  Relationship Between Plasma Lipids and All‐Cause Mortality in Nondemented Elderly , 2005, Journal of the American Geriatrics Society.

[15]  M. Visser,et al.  Lower levels of serum albumin and total cholesterol and future decline in functional performance in older persons: the Longitudinal Aging Study Amsterdam. , 2004, Age and ageing.

[16]  J. Ruidavets,et al.  Obesity and alcohol modulate the effect of apolipoprotein E polymorphism on lipids and insulin. , 2003, Obesity research.

[17]  D. Blazer,et al.  Mortality and apolipoprotein E in African‐American, and White Elders: An attempted replication , 2003, American journal of medical genetics. Part A.

[18]  G. Siest,et al.  The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe , 2002, European Journal of Human Genetics.

[19]  D. Knook,et al.  Association of APOE e2/e3/e4 and Promoter Gene Variants With Dementia But Not Cardiovascular Mortality in Old Age , 2002 .

[20]  A. Hofman,et al.  APOLIPOPROTEIN E AND LONGEVITY: THE ROTTERDAM STUDY , 2001, Journal of the American Geriatrics Society.

[21]  S. Srinivasan,et al.  Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study. , 2001, Metabolism: clinical and experimental.

[22]  R. Corbo,et al.  Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele? , 1999, Annals of human genetics.

[23]  Z Lou,et al.  Tree-structured prediction for censored survival data and the Cox model. , 1995, Journal of clinical epidemiology.

[24]  D. Rader,et al.  In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism. , 1994, Journal of lipid research.

[25]  S M Grundy,et al.  Excess body weight. An under-recognized contributor to dyslipidemia in white American women. , 1994, Archives of internal medicine.

[26]  A. Tall,et al.  Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. , 1993, Journal of lipid research.

[27]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[28]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[29]  T. Lehtimäki,et al.  Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study , 2007, Clinical chemistry and laboratory medicine.

[30]  D. Knook,et al.  Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age. , 2002, American journal of medical genetics.

[31]  E. Eaker,et al.  Serum cholesterol concentrations and all-cause mortality in older people. , 2000, Age and ageing.

[32]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. , 1998, WMJ : official publication of the State Medical Society of Wisconsin.

[33]  K. Watanabe,et al.  Apolipoprotein E polymorphism and hyperlipoproteinemia in obesity. , 1989, International journal of obesity.

[34]  V. Zannis Genetic polymorphism in human apolipoprotein E. , 1986, Methods in enzymology.

[35]  V. Zannis [49] Genetic polymorphism in human apolipoprotein E , 1986 .